Compared to control group, an increase in CCND1 and CD55 mRNA expression was observed in cells treated with PPT, however, this increase did not reach statistical significance (P>0.05, Figure 4A (Fig. 4) ).
← all excerpts
Estrogen receptor subtype agonist activation in human cutaneous squamous cell carcinoma cells modulates expression of CD55 and Cyclin D1.
1
0.0500
0.0500